Arthritis: all 3,553 studies
Page 35 of 36. Open to participants first (311), then studies with results posted, then the rest; newest registration first within each.
- Medical In-Patient Rehabilitation in Rheumatoid ArthritisCompletedNCT00229541Phase 3
- Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid ArthritisCompletedNCT00221000Phase 2
- Comparison of Adalimumab and Infliximab Treatment of Rheumatoid ArthritisStatus unknownNCT00216177Phase 4
- Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid ArthritisCompletedNCT00213564
- Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid ArthritisCompletedNCT00213538
- PEAK Study (Physical Exercise and Activity in Kids)CompletedNCT00213187Phase 2
- Intra-Articular Injection of Botulinum Toxin Type A for Shoulder PainStatus unknownNCT00211718Phase 3
- Intra-articularInjection of Botulinum Toxin TypeStatus unknownNCT00211679Phase 2
- Methotrexate and Cyclosporine in Treatment of Early Rheumatoid ArthritisCompletedNCT00209859Phase 4
- A Multi-centre Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip ReplacementTerminatedNCT00208455Phase 4
- A Multi-centre Study to Assess the Long-term Performance of the Pinnacle™ Cup With a Polyethylene-on-metal Bearing in Primary Total Hip ReplacementWithdrawnNCT00208429Phase 4
- A Multi-centre Study to Assess the Long-term Performance of the Summit™ Hip in Primary Total Hip ReplacementTerminatedNCT00208390Phase 4
- A Multi-centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Primary Hip Resurfacing SurgeryTerminatedNCT00208377Phase 4
- A Two Centre Study to Assess the Long-term Performance of the Pinnacle™ Cup With a Metal-on-Metal Bearing in Primary Total Hip ReplacementTerminatedNCT00208364Phase 4
- Evaluation of the Arthritis Basics for Change (ABCs) Self Management ProgramCompletedNCT00207623Not applicable
- Comparing ASHC and CDSMP Outcomes In ArthritisCompletedNCT00207441Not applicable
- A Comparison of the ASHC and CDSMPCompletedNCT00207415Not applicable
- Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702CompletedNCT00205478Phase 2
- A Placebo-Controlled, Double-Blinded, Randomized Trial of Remicade in Korean Patients With Rheumatoid Arthritis Despite Methotrexate (Study P04280)(COMPLETED)CompletedNCT00202852Phase 3
- Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active Psoriatic ArthritisCompletedNCT00195689Phase 3
- Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in SpainCompletedNCT00195377
- Study Evaluating Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in SpainCompletedNCT00195364
- Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid ArthritisCompletedNCT00185848Phase 1
- Birmingham Hip Resurfacing (BHR) Study: Implantation of a Hip Resurfacing EndoprosthesisStatus unknownNCT00180206Phase 4
- Comparison of Physiotherapy Versus Home Exercise Following Hip Replacement SurgeryCompletedNCT00175448Not applicable
- Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE)Status unknownNCT00172666
- 6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid ArthritisCompletedNCT00170872Phase 3
- Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of GoutCompletedNCT00170781Phase 4
- Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate BackgroundCompletedNCT00162292Phase 1
- The Study of Abatacept in Combination With EtanerceptCompletedNCT00162279Phase 2
- An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF TherapyCompletedNCT00162201Phase 1
- Study Evaluating Etanercept and Methotrexate in Plaque PsoriasisCompletedNCT00161655Phase 4
- A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid ArthritisCompletedNCT00160602Phase 3
- A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231)CompletedNCT00157872Phase 4
- Develop Biomarkers for Assessing RA Joint ErosionStatus unknownNCT00154947
- A Study of Imatinib 400 mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis.CompletedNCT00154336Phase 2
- Effect of Selective COX-2 Inhibition on Ulcer HealingCompletedNCT00153673Phase 3
- Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis PatientsCompletedNCT00153660Phase 3
- Program Evaluation of People With Arthritis Can ExerciseCompletedNCT00153309Phase 2/3
- A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid ArthritisCompletedNCT00152386Phase 3
- Health Benefits of an Exercise Program for Adults With ArthritisCompletedNCT00146393Phase 2/3
- Evaluation of the Active Living Every Day Exercise Program for People With ArthritisCompletedNCT00146367Phase 2/3
- Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)CompletedNCT00144664Phase 3
- Study of MRA in Patients With Rheumatoid Arthritis (RA)CompletedNCT00144651Phase 2
- Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)CompletedNCT00144625Phase 3
- Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)CompletedNCT00144612Phase 3
- Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)CompletedNCT00144599Phase 3
- Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JPCompletedNCT00144586Phase 3
- Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal ImpairmentCompletedNCT00144573Not applicable
- Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA)CompletedNCT00144560Not applicable
- Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JPCompletedNCT00144547Phase 3
- Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA213JPCompletedNCT00144534Phase 3
- Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)CompletedNCT00144521Phase 3
- Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA)CompletedNCT00144508Phase 3
- A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects.CompletedNCT00141934Phase 2
- Study Evaluating ERB-041 With Methotrexate in Rheumatoid ArthritisCompletedNCT00141830Phase 2
- A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid ArthritisCompletedNCT00134693Phase 2
- Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid DisordersCompletedNCT00132418Phase 4
- Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis SubjectsCompletedNCT00126724Phase 1/2
- Study of People With Rheumatoid Arthritis Who Require Joint Surgery in the HandCompletedNCT00124254Not applicable
- Open-Label Extension Safety Study of PROCRIT in Patients With Anemia of Chronic Disease Due to Rheumatoid ArthritisWithdrawnNCT00123149Phase 2
- REKinDLE: Registry With Enbrel® or Kineret® in a Database Using Longitudinal EvaluationsCompletedNCT00121056
- Evaluating Kineret® (Anakinra) in Rheumatoid Arthritis (RA) Subjects Using aSelf-Reported QuestionnaireCompletedNCT00121043Phase 4
- Anakinra (Kineret®) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA)CompletedNCT00117091Phase 3
- Rheumatoid Arthritis DMARD Intervention and UtilizationStudyCompletedNCT00116727
- Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudyCompletedNCT00116714
- Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)CompletedNCT00115219Phase 4
- COX-2 Inhibitor Study In Patients With Rheumatoid ArthritisCompletedNCT00113308Phase 3
- Evaluating the Safety of Extended Treatment With Pegsunercept (PEG sTNF-RI)in Subjects With Rheumatoid Arthritis (RA)CompletedNCT00111423Phase 2
- Evaluating the Effect of Anakinra (r-metHuIL-1ra) on Vaccine AntibodyResponse in Subjects With Rheumatoid Arthritis (RA)CompletedNCT00111410Phase 4
- Enbrel® in Psoriatic ArthritisCompletedNCT00111124Phase 4
- Treatment for Subjects With Active Rheumatoid Arthritis (RA)CompletedNCT00110903Phase 3
- Effects of Pulsed Magnetic Pads on Rheumatoid Arthritis Symptoms in Postmenopausal WomenCompletedNCT00110565Phase 2
- A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid ArthritisCompletedNCT00109408Phase 3
- A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT00106574Phase 3
- A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT00106548Phase 3
- A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate TherapyCompletedNCT00106522Phase 3
- Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX)CompletedNCT00105976Phase 2
- Understanding the Differences in the Management of Patients With Arthritis of the Knee or HipCompletedNCT00105677
- Effectiveness and Safety of Enbrel® (Etanercept) in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab)CompletedNCT00099554Phase 4
- Comparing Tai Chi Chih and Relaxation Therapy in the Treatment of Rheumatoid ArthritisCompletedNCT00096759Phase 2/3
- Study Evaluating TMI-005 in Active Rheumatoid ArthritisCompletedNCT00095342Phase 2
- A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight LossCompletedNCT00094562Phase 2
- Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (Etanercept) Auto-Injector Versus Enbrel® Pre-Filled SyringesCompletedNCT00094341Phase 4
- Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072)CompletedNCT00092742Phase 3
- Juvenile Rheumatoid Arthritis Research RegistryCompletedNCT00090571
- Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque PsoriasisTerminatedNCT00090129Phase 3
- SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving MethotrexateCompletedNCT00089921Phase 2
- Pain and Stress Management for People With Rheumatoid ArthritisCompletedNCT00088764Phase 2
- Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid ArthritisCompletedNCT00078793
- A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid ArthritisCompletedNCT00077870Phase 1/2
- Study Evaluating CCI-779 in Active Rheumatoid Arthritis on Concomitant Methotrexate TherapyTerminatedNCT00076206Phase 2
- Registry for African Americans With Early Rheumatoid ArthritisCompletedNCT00074555
- Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid ArthritisCompletedNCT00074438Phase 2
- Treatment of Rheumatoid Arthritis With Marine and Botanical OilsStatus unknownNCT00072982Phase 3
- Cognitive-Behavioral Therapy and Tai Chi Chih for Patients With Rheumatoid ArthritisCompletedNCT00072657Not applicable
- Meditation-Based Stress Reduction in Rheumatoid ArthritisCompletedNCT00071292Phase 2
- Consistency of Traditional Chinese Medicine Diagnoses and Herbal Prescriptions for Rheumatoid ArthritisCompletedNCT00071149
- Genetic Registry for Rheumatoid ArthritisCompletedNCT00069472
- Health Beliefs and Health Behaviors Among Minorities With Rheumatic DiseasesCompletedNCT00069342